Definition and research guide
This page combines a MeSH definition, publication statistics and selected research abstracts. It is a starting point for reading the literature, not a medical textbook or a systematic evidence review.
Content available: 4 complete abstracts (683 words), 10 references. Full article text is not stored or reproduced here; follow the PMID, DOI or PMC links to read the original sources and their access terms.
Definition
A dosage compensation process occurring at an early embryonic stage in mammalian development whereby, at random, one X chromosome of the pair is repressed in the somatic cells of females.
Definition: NLM Medical Subject Headings (MeSH) scope note (Public domain (U.S. National Library of Medicine); attribution requested). View the MeSH record.
Also known as: Chromosome Inactivation, X; Inactivation, X Chromosome; X-Inactivation; X Inactivation; Inactivation, X; X Inactivations; Lyonization; Lyon Hypothesis.
Where it fits in the MeSH classification
- Broader topics
- Dosage Compensation, Genetic
Related concepts
Research landscape
PubMed indexes 2,312 records tagged with the MeSH heading “X Chromosome Inactivation” (counts retrieved 2026-10-29). 554 of them (24.0%) were published from 2020 onward, and the busiest period so far is 2010-2019 with 1,167 records.
Reviews account for 461 records (19.9%) and meta-analyses for 7. Randomized controlled trials number 1 (0.0%) as a share of all records on the topic. Randomized trials make up only a small share of this literature, so much of what is known comes from laboratory, observational or descriptive work.
Show the data
| Period | Records |
|---|---|
| through 1999 | 0 |
| 2000-2009 | 600 |
| 2010-2019 | 1,167 |
| 2020 onward | 554 |
Publication-type chart data
| Type | Records | Share |
|---|---|---|
| Reviews | 461 | 19.9% |
| Meta-analyses | 7 | 0.3% |
| Randomized controlled trials | 1 | 0.0% |
Method: PubMed query "X Chromosome Inactivation"[MeSH Terms] with publication-type and date filters, retrieved 2026-10-29.
Reading the evidence in genetics and genomics
Genetic findings vary widely in strength. A variant linked to a condition in one study may not replicate in other ancestries, and most common variants have small effects that are meaningful only in aggregate. Studies of rare, high-impact variants can support strong causal claims about a gene, while association studies describe statistical links that need functional and independent replication. Check the sample size, the ancestry of participants, whether results were replicated, and whether a laboratory or clinical outcome was actually measured.
Evidence from open-access studies
These open-access studies come from PubMed’s best-match results for this heading (papers whose main topic it is), ranked here by citation count, with one recent addition. Each abstract is reproduced in full under its recorded open licence so that you can read the authors’ own words. They illustrate the literature; they are not a systematic summary of it. Citation counts measure attention, not reliability or clinical benefit.
| Study / authors | Year | Source label / design | Europe PMC citations | Licence / source |
|---|---|---|---|---|
| Landscape of X chromosome inactivation across human tissues | 2017 | Research article Design not recorded in structured metadata | 989 | cc by PMID 29022598 · DOI · PMC5685192 |
| hnRNPK Recruits PCGF3/5-PRC1 to the Xist RNA B-Repeat to Establish Polycomb-Mediated Chromosomal Silencing | 2017 | Research article Design not recorded in structured metadata | 326 | cc by PMID 29220657 · DOI · PMC5735038 |
| The Implication of Early Chromatin Changes in X Chromosome Inactivation | 2019 | Research article Design not recorded in structured metadata | 274 | cc by PMID 30595450 · DOI · PMC6333919 |
| Escape from X inactivation is directly modulated by Xist noncoding RNA | 2026 | Research article Design not recorded in structured metadata | 11 | cc by PMID 41398052 · DOI · PMC12807875 |
Landscape of X chromosome inactivation across human tissues [1]
Abstract reading summary — source excerpts
- Opening excerpt
- X chromosome inactivation (XCI) silences transcription from one of the two X chromosomes in female mammalian cells to balance expression dosage between XX females and XY males.
- Closing excerpt
- Overall, this updated catalogue of XCI across human tissues helps to increase our understanding of the extent and impact of the incompleteness in the maintenance of XCI.
- Interpretation limits
- Verbatim excerpts from the authors’ abstract; the closing excerpt may describe a finding, limitation or recommendation. Design, population, effect size and uncertainty have not been independently extracted or appraised. Read the complete abstract and linked paper before interpreting the findings.
Read complete abstract (234 words)
X chromosome inactivation (XCI) silences transcription from one of the two X chromosomes in female mammalian cells to balance expression dosage between XX females and XY males. XCI is, however, incomplete in humans: up to one-third of X-chromosomal genes are expressed from both the active and inactive X chromosomes (Xa and Xi, respectively) in female cells, with the degree of 'escape' from inactivation varying between genes and individuals. The extent to which XCI is shared between cells and tissues remains poorly characterized, as does the degree to which incomplete XCI manifests as detectable sex differences in gene expression and phenotypic traits. Here we describe a systematic survey of XCI, integrating over 5,500 transcriptomes from 449 individuals spanning 29 tissues from GTEx (v6p release) and 940 single-cell transcriptomes, combined with genomic sequence data. We show that XCI at 683 X-chromosomal genes is generally uniform across human tissues, but identify examples of heterogeneity between tissues, individuals and cells. We show that incomplete XCI affects at least 23% of X-chromosomal genes, identify seven genes that escape XCI with support from multiple lines of evidence and demonstrate that escape from XCI results in sex biases in gene expression, establishing incomplete XCI as a mechanism that is likely to introduce phenotypic diversity. Overall, this updated catalogue of XCI across human tissues helps to increase our understanding of the extent and impact of the incompleteness in the maintenance of XCI.
Abstract reproduced from the open-access article under the recorded cc by licence; © the authors. PMID 29022598 · DOI · PMC5685192
hnRNPK Recruits PCGF3/5-PRC1 to the Xist RNA B-Repeat to Establish Polycomb-Mediated Chromosomal Silencing [2]
Abstract reading summary — source excerpts
- Opening excerpt
- The Polycomb-repressive complexes PRC1 and PRC2 play a key role in chromosome silencing induced by the non-coding RNA Xist.
- Closing excerpt
- Our findings define a key pathway for Polycomb recruitment by Xist RNA, providing important insights into mechanisms of chromatin modification by non-coding RNA.
- Interpretation limits
- Verbatim excerpts from the authors’ abstract; the closing excerpt may describe a finding, limitation or recommendation. Design, population, effect size and uncertainty have not been independently extracted or appraised. Read the complete abstract and linked paper before interpreting the findings.
Read complete abstract (146 words)
The Polycomb-repressive complexes PRC1 and PRC2 play a key role in chromosome silencing induced by the non-coding RNA Xist. Polycomb recruitment is initiated by the PCGF3/5-PRC1 complex, which catalyzes chromosome-wide H2A lysine 119 ubiquitylation, signaling recruitment of other PRC1 complexes, and PRC2. However, the molecular mechanism for PCGF3/5-PRC1 recruitment by Xist RNA is not understood. Here we define the Xist RNA Polycomb Interaction Domain (XR-PID), a 600 nt sequence encompassing the Xist B-repeat element. Deletion of XR-PID abolishes Xist-dependent Polycomb recruitment, in turn abrogating Xist-mediated gene silencing and reversing Xist-induced chromatin inaccessibility. We identify the RNA-binding protein hnRNPK as the principal XR-PID binding factor required to recruit PCGF3/5-PRC1. Accordingly, synthetically tethering hnRNPK to Xist RNA lacking XR-PID is sufficient for Xist-dependent Polycomb recruitment. Our findings define a key pathway for Polycomb recruitment by Xist RNA, providing important insights into mechanisms of chromatin modification by non-coding RNA.
Abstract reproduced from the open-access article under the recorded cc by licence; © the authors. PMID 29220657 · DOI · PMC5735038
The Implication of Early Chromatin Changes in X Chromosome Inactivation [3]
Abstract reading summary — source excerpts
- Opening excerpt
- During development, the precise relationships between transcription and chromatin modifications often remain unclear.
- Closing excerpt
- Our results reveal the hierarchy of chromatin events during the initiation of XCI and identify key roles for chromatin in the early steps of transcriptional silencing.
- Interpretation limits
- Verbatim excerpts from the authors’ abstract; the closing excerpt may describe a finding, limitation or recommendation. Design, population, effect size and uncertainty have not been independently extracted or appraised. Read the complete abstract and linked paper before interpreting the findings.
Read complete abstract (152 words)
During development, the precise relationships between transcription and chromatin modifications often remain unclear. We use the X chromosome inactivation (XCI) paradigm to explore the implication of chromatin changes in gene silencing. Using female mouse embryonic stem cells, we initiate XCI by inducing Xist and then monitor the temporal changes in transcription and chromatin by allele-specific profiling. This reveals histone deacetylation and H2AK119 ubiquitination as the earliest chromatin alterations during XCI. We show that HDAC3 is pre-bound on the X chromosome and that, upon Xist coating, its activity is required for efficient gene silencing. We also reveal that first PRC1-associated H2AK119Ub and then PRC2-associated H3K27me3 accumulate initially at large intergenic domains that can then spread into genes only in the context of histone deacetylation and gene silencing. Our results reveal the hierarchy of chromatin events during the initiation of XCI and identify key roles for chromatin in the early steps of transcriptional silencing.
Abstract reproduced from the open-access article under the recorded cc by licence; © the authors. PMID 30595450 · DOI · PMC6333919
Escape from X inactivation is directly modulated by Xist noncoding RNA [4]
Abstract reading summary — source excerpts
- Opening excerpt
- In placental XX females, one X chromosome is silenced during a narrow developmental time window by X-chromosome inactivation, which is mediated by Xist noncoding RNA.
- Closing excerpt
- Thus, gene activity and three-dimensional topology of the inactive X chromosome are directly controlled by Xist, well beyond an early developmental time window.
- Interpretation limits
- Verbatim excerpts from the authors’ abstract; the closing excerpt may describe a finding, limitation or recommendation. Design, population, effect size and uncertainty have not been independently extracted or appraised. Read the complete abstract and linked paper before interpreting the findings.
Read complete abstract (151 words)
In placental XX females, one X chromosome is silenced during a narrow developmental time window by X-chromosome inactivation, which is mediated by Xist noncoding RNA. Although most X-linked genes are silenced during X-chromosome inactivation, some genes can escape. Here, by increasing its endogenous level, we show that Xist RNA can silence escapees well beyond early embryogenesis both in vitro, in differentiated cells, as well as in vivo, in mouse pre- and post-implantation embryos. We further demonstrate that Xist RNA plays a role in eliminating topologically associating domain-like structures spanning clusters of escapees, and this is dependent on SPEN. The function of Xist in silencing escapees and eliminating topological domains is initially fully reversible, but sustained Xist upregulation leads to irreversible silencing and CpG island DNA methylation of escapees. Thus, gene activity and three-dimensional topology of the inactive X chromosome are directly controlled by Xist, well beyond an early developmental time window.
Abstract reproduced from the open-access article under the recorded cc by licence; © the authors. PMID 41398052 · DOI · PMC12807875
Key reviews and meta-analyses
The most cited review-type papers among PubMed’s best-match results for this heading, listed with bibliographic details only. Follow the links for the full text and access terms.
- Research article Meiotic sex chromosome inactivation [5]
- Research article X-inactivation, imprinting, and long noncoding RNAs in health and disease [6]
- Research article Genes that escape from X inactivation [7]
- Research article Regulation of X-chromosome inactivation by the X-inactivation centre [8]
- Research article Gene silencing in X-chromosome inactivation: advances in understanding facultative heterochromatin formation [9]
- Research article X chromosome regulation: diverse patterns in development, tissues and disease [10]
References
- Tukiainen T, Villani AC, Yen A, Rivas MA, Marshall JL, Satija R, et al.. Landscape of X chromosome inactivation across human tissues. . 2017. PMID 29022598 · DOI · PMC5685192
- Pintacuda G, Wei G, Roustan C, Kirmizitas BA, Solcan N, Cerase A, et al.. hnRNPK Recruits PCGF3/5-PRC1 to the Xist RNA B-Repeat to Establish Polycomb-Mediated Chromosomal Silencing. . 2017. PMID 29220657 · DOI · PMC5735038
- Żylicz JJ, Bousard A, Žumer K, Dossin F, Mohammad E, da Rocha ST, et al.. The Implication of Early Chromatin Changes in X Chromosome Inactivation. . 2019. PMID 30595450 · DOI · PMC6333919
- Hauth A, Panten J, Kneuss E, Picard C, Servant N, Rall I, et al.. Escape from X inactivation is directly modulated by Xist noncoding RNA. . 2026. PMID 41398052 · DOI · PMC12807875
- Turner JM. Meiotic sex chromosome inactivation. Development. 2007. PMID 17329371 · DOI
- Lee JT, Bartolomei MS. X-inactivation, imprinting, and long noncoding RNAs in health and disease. Cell. 2013. PMID 23498939 · DOI
- Berletch JB, Yang F, Xu J, Carrel L, Disteche CM. Genes that escape from X inactivation. Hum Genet. 2011. PMID 21614513 · DOI · PMC3136209
- Augui S, Nora EP, Heard E. Regulation of X-chromosome inactivation by the X-inactivation centre. Nat Rev Genet. 2011. PMID 21587299 · DOI
- Wutz A. Gene silencing in X-chromosome inactivation: advances in understanding facultative heterochromatin formation. Nat Rev Genet. 2011. PMID 21765457 · DOI
- Deng X, Berletch JB, Nguyen DK, Disteche CM. X chromosome regulation: diverse patterns in development, tissues and disease. Nat Rev Genet. 2014. PMID 24733023 · DOI · PMC4117651
About this article
- Sources
- NLM Medical Subject Headings (definition, synonyms); NCBI PubMed (counts, identifiers); Europe PMC (open-access abstracts and citation counts).
- Verification
- Every reference was resolved against PubMed on 2026-10-31; title, year and DOI matched.
- Review state
- automated source verified; no human expert review has been recorded yet.
- Version
- 1, last updated 2026-10-29.
See how EvidenceLib is built. Spotted an error? Email support@evidencehelix.com.
Evidence strength
EvidenceHelix's computed view of the study designs behind this topic: how common meta-analyses, randomized trials and reviews are, how recent the literature is, and a plain-language reading. It describes the design mix of the literature. It is not a quality appraisal of any study, and it is not medical advice.